MoonLake Immunotherapeutics MLTX Future pension and postretirement benefit obligations
Future pension and postretirement benefit obligations at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's future pension and postretirement benefit obligations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's future pension and postretirement benefit obligations?
- MoonLake Immunotherapeutics (MLTX) reported future pension and postretirement benefit obligations of $353K in Q1 2026.
- How has MoonLake Immunotherapeutics's future pension and postretirement benefit obligations changed year-over-year?
- MoonLake Immunotherapeutics's future pension and postretirement benefit obligations decreased by 34.1% year-over-year, from $536K to $353K.
- What is the long-term trend for MoonLake Immunotherapeutics's future pension and postretirement benefit obligations?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's future pension and postretirement benefit obligations has grown at a -100.0% compound annual growth rate (CAGR), from $239.86K to $0.